News
03-16-2009, 02:22 PM
Liz Hardaker, medical director of Cephalon UK. "We are disappointed and surprised that NICE has not taken this opportunity to distinguish between different forms of anthracycline treatment; specifically the use of liposomal-encapsulated doxorubicin. "Myocet, in combination with cyclophosphamide, is indicated for the first line treatment of metastatic breast cancer in women (SmPC).
More... (http://www.medicalnewstoday.com/articles/142136.php)
More... (http://www.medicalnewstoday.com/articles/142136.php)